Expression of fission/fusion proteins in patient samples and highly established cancer cell lines reveals that fission-promoting proteins often have higher expression in localized and disseminated tumorigenic tissue and metastatic cancer cell lines compared to normal tissue or normal immortalized cell lines, respectively (Table 2). This evidence concerns the gene PROS1 and metastatic malignant neoplasm.